Valsartan alleviates the blood–brain barrier dysfunction in db/db diabetic mice
Type 2 diabetes (T2D)-related neurological complication is the risk factor for neurodegenerative disorders. The pathological changes from T2D-caused blood–brain barrier (BBB) dysfunction plays a critical role in developing neurodegeneration. The hyper-activation of the Angiotensin II type 1 receptor...
Guardado en:
Autores principales: | Longxue Cai, Wenfeng Li, Renqing Zeng, Zuohong Cao, Qicai Guo, Qi Huang, Xianfa Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19354ee41a994ffa90f4b8afb3875ce8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney
por: Du,Guankui, et al.
Publicado: (2017) -
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
por: Lv J, et al.
Publicado: (2020) -
On the Modeling of Microstrip Lines Loaded With Dumbbell Defect-Ground-Structure (DB-DGS) and Folded DB-DGS Resonators
por: Lijuan Su, et al.
Publicado: (2021) -
Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway
por: Haifei Xie, et al.
Publicado: (2022) -
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
por: Zhang C, et al.
Publicado: (2019)